+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computer-aided Drug Discovery Market - Global Forecast 2026-2032- Product Image
Computer-aided Drug Discovery Market - Global Forecast 2026-2032- Product Image
New

Computer-aided Drug Discovery Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967979
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The computer-aided drug discovery market is experiencing notable transformation, driven by swift technological advancements, changing procurement strategies, and evolving collaboration models. Senior leaders navigating the sector must recognize the impact of converging data standards, algorithmic breakthroughs, and adaptable deployment options on strategic drug development.

Market Snapshot: Computer-Aided Drug Discovery

The computer-aided drug discovery market grew from USD 4.49 billion in 2025 to USD 4.90 billion in 2026. It is expected to continue growing at a CAGR of 10.08%, reaching USD 8.80 billion by 2032. This upward trajectory is propelled by the fusion of computational power, improved interoperability, and rapid automation capabilities, as organizations globally accelerate digital transformation across drug discovery pipelines.

Scope & Segmentation

  • Molecule Classes: Adoption patterns differ between biologics—where structural biology and genomics are emphasized—and small molecules, which rely on chemoinformatics, QSAR modeling, and virtual screening.
  • Deployment Choices: Cloud-based solutions enable scalable, collaborative workflows, while many organizations opt for on-premises installations to prioritize data sovereignty and integration with legacy infrastructure.
  • Pricing Structures: Organizations select from pay-per-use models for high-intensity computing, perpetual licenses for rigorous internal control, and subscriptions for predictable budgeting coupled with ongoing updates.
  • End Users: Academic, government, contract research, biotech, and pharmaceutical organizations all exhibit distinct preferences for transparency, flexibility, modularity, or compliance.
  • Product Types: Services encompass consulting, research outsourcing, support, and system implementation; software includes analytics, de novo design, molecular modeling, and virtual screening platforms.
  • Technologies: Core specializations span ADMET prediction, bioinformatics, chemoinformatics, de novo molecular design, and both ligand- and structure-based modeling tools.
  • Application Domains: Solutions address critical needs in clinical trial support, target identification, lead discovery, optimization, and preclinical development programs.
  • Regional Markets: Americas, Europe, Middle East & Africa, and Asia-Pacific each display unique dynamics influenced by regulatory frameworks, infrastructure investment, and workforce availability.

Key Takeaways for Strategic Decision-Makers

  • Integration of computational and experimental workflows streamlines early-stage candidate selection and supports more targeted, translationally relevant strategies across R&D.
  • Advancements in algorithm interpretability and cloud infrastructure are reducing collaboration barriers, paving the way for reproducible, auditable research pipelines.
  • Flexible deployment models cater to compliance requirements and organizational scale, driving faster technology adoption by teams of all sizes.
  • Service-oriented vendor relationships—combining consulting, validation, and ongoing operational support—facilitate smooth technology integration and consistent value realization.
  • Regional initiatives in Asia-Pacific and the Americas are fueling rapid capacity building and cross-border collaborations, while Europe, Middle East & Africa emphasize compliance and interoperable standards.
  • Providers are adopting modular, interoperable platforms to support multi-vendor stacks, making it easier for organizations to scale specialized capabilities as business or regulatory demands evolve.

Tariff Impact: Procurement and Deployment Shifts

Recent tariff measures are increasing costs for specialized laboratory consumables, computational hardware, and certain software licenses. R&D organizations are adapting by redirecting procurement to domestic or alternative vendors, optimizing workflows to reduce reliance on tariff-impacted inputs, and reassessing both cloud and on-premises deployment locations based on data residency needs. Shared procurement strategies are emerging in research collaborations, and early-stage design now factors in supply chain resilience to ensure project continuity despite fluctuating costs and administrative requirements.

Methodology & Data Sources

This report leverages expert interviews, technical evaluations, and a thorough literature review. Insights derive from direct practitioner feedback across scientific, technical, and procurement roles, supported by in-depth assessment of representative platforms, compliance documentation, and peer-reviewed research.

Why This Report Matters

  • Enables senior leaders to benchmark technology selection, deployment, and procurement strategies against industry standards and evolving best practices.
  • Facilitates informed investment decisions with nuanced segmentation and actionable insights into vendor capabilities and partnership models.
  • Supports risk management and operational alignment by clarifying the effects of tariffs, regulatory compliance, and dynamic innovation drivers on long-term discovery programs.

Conclusion

Integrated computational strategies are redefining efficiency, reproducibility, and decision-making in drug discovery. Senior leaders equipped with a clear understanding of regional dynamics, technology trends, and collaborative models are poised to drive resilient, high-impact R&D outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Computer-aided Drug Discovery Market, by Molecule Type
8.1. Biologics
8.2. Small Molecules
9. Computer-aided Drug Discovery Market, by Deployment Model
9.1. Cloud-Based
9.2. On-Premises
10. Computer-aided Drug Discovery Market, by Pricing Model
10.1. Pay Per Use
10.2. Perpetual License
10.3. Subscription
11. Computer-aided Drug Discovery Market, by Type
11.1. Services
11.1.1. Consulting
11.1.2. Implementation
11.1.3. Research Outsourcing
11.1.4. Support And Maintenance
11.2. Software
11.2.1. Data Analytics
11.2.2. De Novo Design
11.2.3. Molecular Modeling
11.2.3.1. Ligand Based Design
11.2.3.2. Structure Based Design
11.2.4. QSAR Modeling
11.2.5. Virtual Screening
12. Computer-aided Drug Discovery Market, by Technology
12.1. ADMET Prediction
12.2. Bioinformatics
12.2.1. Functional Genomics
12.2.2. Sequence Analysis
12.3. Chemoinformatics
12.3.1. Library Design
12.3.2. QSAR Modeling
12.3.3. Scaffold Hopping
12.4. De Novo Design
12.5. Molecular Modeling
13. Computer-aided Drug Discovery Market, by Application
13.1. Clinical Trials Support
13.2. Lead Discovery
13.3. Lead Optimization
13.4. Preclinical Development
13.5. Target Identification
14. Computer-aided Drug Discovery Market, by End User
14.1. Academic And Government Institutes
14.2. Biotechnology Companies
14.3. Contract Research Organizations
14.4. Pharmaceutical Companies
15. Computer-aided Drug Discovery Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Computer-aided Drug Discovery Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Computer-aided Drug Discovery Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Computer-aided Drug Discovery Market
19. China Computer-aided Drug Discovery Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. AbbVie Inc.
20.6. Accelrys, Inc.
20.7. AstraZeneca PLC
20.8. Bayer AG
20.9. Bio-Rad Laboratories, Inc.
20.10. Boehringer Ingelheim International GmbH
20.11. Chemical Computing Group Inc.
20.12. Dassault Systèmes SE
20.13. Eli Lilly and Company
20.14. Gilead Sciences, Inc.
20.15. GlaxoSmithKline PLC
20.16. Merck & Co., Inc.
20.17. Novartis AG
20.18. Pfizer Inc.
List of Figures
FIGURE 1. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 187. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 188. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 190. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 192. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 212. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 213. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 214. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 215. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 216. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 217. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 218. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 239. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 240. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 241. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 242. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 243. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 244. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 245. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 247. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 248. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. ASEAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 252. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 253. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 254. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 255. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 256. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 257. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 258. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 260. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 261. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. GCC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 278. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 279. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 280. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 282. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 283. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 284. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 286. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 287. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. BRICS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 290. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 291. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 292. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
TABLE 293. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 294. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 295. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 296. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2032 (USD MILLION)
TABLE 297. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 298. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 299. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 300. G7 COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE,

Companies Mentioned

The key companies profiled in this Computer-aided Drug Discovery market report include:
  • AbbVie Inc.
  • Accelrys, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim International GmbH
  • Chemical Computing Group Inc.
  • Dassault Systèmes SE
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.9 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.8 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Computer-Aided Drug Discovery Market Report 2025 - Product Image

Computer-Aided Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Computer-Aided Drug Discovery - Global Strategic Business Report - Product Image

Computer-Aided Drug Discovery - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032 - Product Image

Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Drug Discovery Informatics Market - Global Forecast 2026-2032 - Product Image

Drug Discovery Informatics Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Drug Discovery Services - Company Evaluation Report, 2025 - Product Image

Drug Discovery Services - Company Evaluation Report, 2025

  • Report
  • 155 Pages
  • Global
From

About the Computer Aided Drug Discovery Market

Computer Aided Drug Discovery (CADD) is a technology-driven approach to drug discovery that uses computer-based methods to identify and develop new drugs. CADD combines the power of computational chemistry, bioinformatics, and machine learning to identify and optimize potential drug candidates. CADD can be used to identify novel drug targets, design and optimize drug molecules, and predict drug-target interactions. CADD can also be used to predict drug metabolism and toxicity, and to identify potential drug-drug interactions. CADD has become an important tool in the drug discovery process, allowing researchers to rapidly identify and develop new drugs. CADD can reduce the time and cost associated with drug discovery, and can help to identify novel drug targets and optimize drug molecules. Some companies in the CADD market include Schrödinger, ChemAxon, Accelrys, and OpenEye Scientific Software. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.